Vietnam to produce Pfizer’s COVID-19 treatment pills

Vietnamese pharmaceutical company Stellapharm has been licensed by international public health group Medicines Patent Pool (MPP) to produce Pfizer's COVID-19 treatment pills containing the active ingredient nirmatrelvir.

Vietnamese enterprise Stellapharm has been licensed to produce Paxlovid, Pfizer's COVID-19 pills  (Photo: Reuters)

Vietnamese enterprise Stellapharm has been licensed to produce Paxlovid, Pfizer's COVID-19 pills  (Photo: Reuters)

Stellapharm represents the only Vietnamese enterprise among 35 companies throughout 12 countries that have been franchised by MPP to produce such pills.

The 12 licensed franchisees include firms in Bangladesh, Brazil, China, Dominican Republic, Jordan, India, Israel, Mexico, Pakistan, Serbia, the Republic of Korea, and Vietnam.

Pfizer's drug, which is to be sold under the commercial name Paxlovid, was granted approval by the US Food and Drug Administration (FDA) in December, 2021.

Canada, the United Kingdom, and the European Medicines Agency (EMA) all allowed the drug to be used to treat patients from the age of 12, as well as old people suffering from underlying diseases such as obesity and diabetes.

The drug reduces the risk of hospitalisation or death by 88%, whilst it is also effective against the Omicron variant, according to health experts

Charles Gore, CEO of MPP, said nirmatrelvir is a new pharmaceutical product that requires significant manufacturing capacity, adding those franchisees have demonstrated their capability to meet MPP's requirements and produce products meeting international quality standards.

The franchise is expected to help bring the drug to countries that make up around 53% of the world’s population.

In December 2021, Pfizer, the owner of the nirmatrelvir drug patent, authorised MPP to review applications and sign contracts with pharmaceutical companies which are eligible to produce the drug in the global supply chain.

The Drug Administration of Vietnam under the Ministry of Health sent an official dispatch to the Vietnam Pharmaceutical Companies Association, requesting that local drug manufacturers be notified to submit their documents to become a franchise partner.

Earlier in January, Stellapharm was the only local pharmaceutical company licensed by MPP to produce drug maker MSD’s molnupiravir. The oral drug has been supplied to 105 low and middle-income countries.

At present, there are four types of antiviral active ingredients available to treat COVID-19 in Vietnam. Remdesivir is intravenously used for critically-ill patients, while molnupiravir, favipiravir, and nirmatrelvir are treatment pills for patients with mild symptoms.

At present, there are currently four types of antiviral active ingredients available to treat COVID-19, including remdesivir which is intravenously used for critically-ill patients, and three types of treatment pills, including molnupiravir, favipiravir, and nirmatrelvir for patients with mild symptoms.

VOV

Other News

Vietnam moves to adapt to rapid population ageing, expand silver economy

Vietnam moves to adapt to rapid population ageing, expand silver economy

The International Day of Older Persons 2026, themed “The Age of Longevity: Rethinking Systems for Longer Lives,” highlights the need to develop healthcare, social security, labour-market and social-service systems in response to increasing life expectancy. For Vietnam, rapid population ageing is not only a demographic issue but also a development challenge.

Vietnamese, Lao localities bolster Front cooperation

Vietnamese, Lao localities bolster Front cooperation

Both sides agreed to keep educating officials, Party members, youth union groups and the broader public, especially young people in both provinces, on the great friendship, special solidarity, comprehensive cooperation and strategic cohesion between Vietnam and Laos.

Urgent rescue launched for Merchant Mariner off Quang Ngai

Urgent rescue launched for Merchant Mariner off Quang Ngai

The captain discovered water entering ballast tanks No. 4, 5 and 6 on the port side, causing the vessel to list slightly. Initial assessments indicated that the vessel may have struck an underwater rock formation while underway.

Publishing copyright caught in crossfire of piracy, AI

Publishing copyright caught in crossfire of piracy, AI

Publishing copyright is entering an entirely new phase. As AI becomes increasingly capable of generating text, summarising books, mimicking writing styles and producing content at enormous speed, ensuring copyright protection is becoming more difficult.

Heavy rains cause widespread damage in Phu Tho, Thanh Hoa

Heavy rains cause widespread damage in Phu Tho, Thanh Hoa

Prolonged heavy rains from September 13–17 have caused flooding and landslides, damaging homes, crops, roads and infrastructure in Phu Tho and Thanh Hoa provinces, with local authorities mobilising forces for emergency response.

Quang Ninh police bust 38.4 million USD transnational cybercrime ring

Quang Ninh police bust 38.4 million USD transnational cybercrime ring

Quang Ninh city's Public Security Department warned individuals, agencies and businesses not to publicly disclose or provide personal information or bank account details on social media, and urged organisations and businesses to strictly comply with regulations on protecting customers’ personal data.

Search area expanded to recover more martyrs' remains in Quang Tri

Search area expanded to recover more martyrs' remains in Quang Tri

The continued recovery of martyrs’ remains provides valuable information and further evidence of those who fought and sacrificed their lives for national independence and freedom. It also encourages search teams to persist in locating fallen soldiers still lying on former battlefields, contributing to the effective implementation of the 500-day campaign and reflecting Vietnam’s long-standing tradition of gratitude.

Vietnam to screen students nationwide for five health risks from 2028

Vietnam to screen students nationwide for five health risks from 2028

Vietnam will launch nationwide screening for five groups of school-related diseases and health conditions among students from preschool through high school from 2028, including overweight and obesity, refractive errors, spinal curvature, oral diseases and mental health disorders.